bibliographic entry 1463580 [be/1463580]
https://w3id.org/oc/corpus/be/1463580

is a
content
  • Seiden, M.V, Burris, H.A, Matulonis, U, Hall, J.B, Armstrong, D.K, Speyer, J, Weber, J.D.A, Muggia, F. A phase II trial of EMD72000 (matuzumab), a humanized anti-EGFR monoclonal antibody, in patients with platinum-resistant ovarian and primary peritoneal malignancies, Gynecol. Oncol, 2007, 104, 727, 731, DOI: 10.1016/j.ygyno.2006.10.019, PMID: 17126894
references